The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce a new partnership with Pfizer, focussing on the development of centres of excellence for Antimicrobial Stewardship (AMS) practice, with the goal of reducing inequities in access to AMS programmes and improving patient outcomes.

The landmark Global Research on Antimicrobial Resistance (GRAM) report, which was published in The Lancet today, will ring alarm bells at the highest levels of government, health leaders and policymakers around the world. The report, which reviews data from 204 countries and territories, gives the best estimate yet of the scale of antimicrobial resistance (AMR) globally.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance (AMR). In this post, Dr Alix Brazier, Sarah Merriam and David Halpern, of the UK’s Behavioural Insights Team (BIT), explore how applying behavioural science can impact AMR…